ethosuximide has been researched along with Chronic Disease in 4 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, dose-response studies showed that lower doses of CGP35348 that failed to influence atypical absence seizure activity, completely reversed the spatial working memory deficit." | 1.33 | GABAB receptor antagonism abolishes the learning impairments in rats with chronic atypical absence seizures. ( Burnham, WM; Chan, KF; Cortez, MA; Jia, Z; Snead, OC, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, KF | 1 |
| Burnham, WM | 1 |
| Jia, Z | 1 |
| Cortez, MA | 1 |
| Snead, OC | 1 |
| Penin, H | 1 |
| Hohenauer, I | 1 |
| Schmoigl, S | 1 |
| Rabe, F | 1 |
1 review available for ethosuximide and Chronic Disease
| Article | Year |
|---|---|
[Long-term anticonvulsant therapy (author's transl)].
Topics: Anticonvulsants; Carbamazepine; Chronic Disease; Clonazepam; Epilepsy; Ethosuximide; Humans; Long-Te | 1978 |
3 other studies available for ethosuximide and Chronic Disease
| Article | Year |
|---|---|
GABAB receptor antagonism abolishes the learning impairments in rats with chronic atypical absence seizures.
Topics: Animals; Anticholesteremic Agents; Anticonvulsants; Chronic Disease; Disease Models, Animal; Dose-Re | 2006 |
[Experience with a combination of ethosuximide and mepacrine (Acrisuxin) in the treatment of chronic epileptic seizures in children].
Topics: Child; Child, Preschool; Chronic Disease; Drug Combinations; Epilepsy; Epilepsy, Absence; Epilepsy, | 1972 |
[Drug treatment of chronic epilepsy].
Topics: Anticonvulsants; Carbamazepine; Chronic Disease; Epilepsy; Ethosuximide; Humans; Hydantoins; Primido | 1970 |